Shares in Roche Holding (ROG.S), opens new tab rose around 2% on Monday, outperforming a broadly unchanged European healthcare index (.SXDP), opens new tab, as the drugmaker said it was advancing its experimental obesity drug CT-388 to a late-stage clinical trial.
The Swiss drugmaker was presenting an update on its obesity drugs pipeline at an investor day in London.
